ATR Stock Overview
Designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 1/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Narratives bring a range of perspectives from our community.
AptarGroup, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$163.09 |
52 Week High | US$178.03 |
52 Week Low | US$122.29 |
Beta | 0.57 |
1 Month Change | -2.04% |
3 Month Change | 6.55% |
1 Year Change | 29.20% |
3 Year Change | 41.34% |
5 Year Change | 42.15% |
Change since IPO | 3,245.44% |
Recent News & Updates
AptarGroup Has Gotten Too Expensive
Dec 02These 4 Measures Indicate That AptarGroup (NYSE:ATR) Is Using Debt Reasonably Well
Nov 28Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching
Nov 14Are Investors Undervaluing AptarGroup, Inc. (NYSE:ATR) By 46%?
Oct 28Recent updates
AptarGroup Has Gotten Too Expensive
Dec 02These 4 Measures Indicate That AptarGroup (NYSE:ATR) Is Using Debt Reasonably Well
Nov 28Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching
Nov 14Are Investors Undervaluing AptarGroup, Inc. (NYSE:ATR) By 46%?
Oct 28Risks To Shareholder Returns Are Elevated At These Prices For AptarGroup, Inc. (NYSE:ATR)
Oct 14Return Trends At AptarGroup (NYSE:ATR) Aren't Appealing
Sep 17Is AptarGroup (NYSE:ATR) A Risky Investment?
Aug 16AptarGroup, Inc. (NYSE:ATR) Just Released Its Second-Quarter Earnings: Here's What Analysts Think
Jul 31AptarGroup: Shares Are Pumped Up
Jul 16AptarGroup (NYSE:ATR) Has Announced That It Will Be Increasing Its Dividend To $0.45
Jul 15Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching
Jul 02Getting In Cheap On AptarGroup, Inc. (NYSE:ATR) Is Unlikely
Jun 19Calculating The Intrinsic Value Of AptarGroup, Inc. (NYSE:ATR)
Jun 05Here's Why Shareholders May Want To Be Cautious With Increasing AptarGroup, Inc.'s (NYSE:ATR) CEO Pay Packet
Apr 25AptarGroup (NYSE:ATR) Has A Pretty Healthy Balance Sheet
Mar 28Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching
Mar 07Risks To Shareholder Returns Are Elevated At These Prices For AptarGroup, Inc. (NYSE:ATR)
Feb 21AptarGroup, Inc. (NYSE:ATR) Shares Could Be 23% Below Their Intrinsic Value Estimate
Feb 08AptarGroup (NYSE:ATR) Has More To Do To Multiply In Value Going Forward
Jan 26AptarGroup: Exceptional Quality, But Priced For Perfection
Jan 18AptarGroup: The Market Price Has Run Ahead Of Its Performance
Oct 20AptarGroup: There Are Better Prospects Out There
Jul 29AptarGroup Non-GAAP EPS of $0.92 beats by $0.13, revenue of $795.91M beats by $20.34M
Feb 16Aptar Pharma launches nasal spray pump
Jan 30AptarGroup: A Solid Business That's Just A Bit Too Pricey
Jan 17AptarGroup realigns two business reporting segments
Dec 13Shareholder Returns
ATR | US Packaging | US Market | |
---|---|---|---|
7D | -4.6% | -1.6% | 0.04% |
1Y | 29.2% | 16.2% | 27.3% |
Return vs Industry: ATR exceeded the US Packaging industry which returned 16.2% over the past year.
Return vs Market: ATR exceeded the US Market which returned 27.3% over the past year.
Price Volatility
ATR volatility | |
---|---|
ATR Average Weekly Movement | 2.5% |
Packaging Industry Average Movement | 3.7% |
Market Average Movement | 6.2% |
10% most volatile stocks in US Market | 16.9% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ATR has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: ATR's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1992 | 13,800 | Stephan Tanda | www.aptar.com |
AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions.
AptarGroup, Inc. Fundamentals Summary
ATR fundamental statistics | |
---|---|
Market cap | US$11.15b |
Earnings (TTM) | US$335.95m |
Revenue (TTM) | US$3.57b |
32.3x
P/E Ratio3.0x
P/S RatioIs ATR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ATR income statement (TTM) | |
---|---|
Revenue | US$3.57b |
Cost of Revenue | US$2.23b |
Gross Profit | US$1.34b |
Other Expenses | US$1.00b |
Earnings | US$335.95m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 5.05 |
Gross Margin | 37.45% |
Net Profit Margin | 9.40% |
Debt/Equity Ratio | 42.0% |
How did ATR perform over the long term?
See historical performance and comparison